The RESTORE trial: What did we learn about multiple sclerosis?

被引：1
|
作者：
Karceski, Steven
机构：
来源：
NEUROLOGY | 2014年 / 82卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000000423
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In their article MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study,(1) Fox and colleagues carefully evaluated a very specific question: what happens if a specific treatment for multiple sclerosis (MS) is temporarily stopped? To many people, this would seem an unusual question. It does not seem logical. Why would a treatment, if it were working, be stopped? The answer is that some treatments can have long-term side effects. In others, like natalizumab, it has been observed that long-term treatment, which is aimed at the immune system, can cause problems with the way that our bodies respond to certain viruses.
引用
下载
收藏
页码：E155 / E157
页数：3
相关论文
共 50 条
  • [1] What Did We Learn About Pandemic Communication?
    Palmedo, P. Christopher
    JOURNAL OF HEALTH COMMUNICATION, 2023, 28 : 1 - 1
  • [2] What did we learn from the ARUBA trial?
    Russin, Jonathan
    Cohen-Gadol, Aaron A.
    NEUROSURGICAL FOCUS, 2014, 37 (03)
  • [3] What did we learn about Interdisciplinary Collaboration in Institutions?
    Muller, J
    Shore, WB
    Martin, P
    Levine, M
    Harvey, H
    Kelly, P
    McCarty, S
    Szarek, J
    Veitia, M
    ACADEMIC MEDICINE, 2001, 76 (04) : S55 - S60
  • [4] What did we learn about early clinical experience?
    O'Brien-Gonzales, A
    Blavo, C
    Barley, G
    Steinkohl, DC
    Loeser, H
    ACADEMIC MEDICINE, 2001, 76 (04) : S49 - S54
  • [5] What did we teach; what did they learn?
    Pratt, Dan
    MEDICAL TEACHER, 2024, 46 (10) : 1378 - 1378
  • [6] The Asian crisis: what did we learn and when did we learn it?
    Grenville, Stephen
    ASIAN-PACIFIC ECONOMIC LITERATURE, 2017, 31 (02) : 30 - 44
  • [7] What did we learn about the impact on students' clinical education?
    Barley, G
    O'Brien-Gonzales, A
    Hughes, E
    ACADEMIC MEDICINE, 2001, 76 (04) : S68 - S71
  • [8] What did we learn and what will we learn from hydrodynamics at RHIC?
    Kolb, PF
    INTERSECTIONS OF PARTICLE AND NUCLEAR PHYSICS, 2003, 698 : 694 - 697
  • [9] Fukushima - what did we learn?
    Pearce, Keith
    NUCLEAR ENGINEERING INTERNATIONAL, 2019, 64 (774): : 22 - 23
  • [10] What did we learn from multiple omics studies in asthma?
    Ivanova, Olga
    Richards, Levi B.
    Vijverberg, Susanne J.
    Neerincx, Anne H.
    Sinha, Anirban
    Sterk, Peter J.
    Maitland-van der Zee, Anke H.
    ALLERGY, 2019, 74 (11) : 2129 - 2145
12345